News & Analysis on Clinical Trial Services & Contract Research And Development
Cyprotex launches in vitro toxicology service, Cyprotox, after extending laboratory space at its Macclesfield, UK facility by 90 sq m. This gives the UK site the same in vitro capabilities as those of Apredica, US, which Cyprotex acquired in August.
The US Alzheimer’s Association has created ‘TrialMatch’, a free online tool enabling people with Alzheimer’s or related dementias to actively search for opportunities to enrol in clinical research trials.
Stabilitech is increasing the temperature range tolerance and ambient storage lifespan of two vaccines for the US military.
Proposed changes to USP chapters 232 and 233 on trace impurities would increase drug industry use of automated analysis, creating “huge number” of potential new customers says Thermo Fisher Scientific.
The FDA has approved Alexion Pharmaceuticals’ Rhode Island, US plant for commercial supply of Soliris (eculizumab), giving the biopharm a second source.
Spaulding Clinical has renovated its Phase I pharmacology unit, citing both sponsor and regulatory demand for centralized cardiac monitoring as drivers.